Clinical/scientific notes

F. Castrop; M. C. Kowarik; H. Albrecht; M. Krause; B. Haslinger; C. Zimmer; A. Berthele; B. Hemmer

doi:10.1212/WNL.0b013e31824c46ad

Clinical/scientific notes

F. Castrop, M. C. Kowarik, H. Albrecht, M. Krause, B. Haslinger, C. Zimmer, A. Berthele, B. Hemmer

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

39 Zitate (Scopus)

Originalsprache	Englisch
Seiten (von - bis)	928-930
Seitenumfang	3
Fachzeitschrift	Neurology
Jahrgang	78
Ausgabenummer	12
DOIs	https://doi.org/10.1212/WNL.0b013e31824c46ad
Publikationsstatus	Veröffentlicht - 20 März 2012
Extern publiziert	Ja

Zugriff auf Dokument

10.1212/WNL.0b013e31824c46ad

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{ff6f9cd58bdf4964bcab42b926a83154,

title = "Clinical/scientific notes",

author = "F. Castrop and Kowarik, {M. C.} and H. Albrecht and M. Krause and B. Haslinger and C. Zimmer and A. Berthele and B. Hemmer",

note = "Funding Information: Dr. Castrop has received funding for travel from Allergan, Biogen Idec, Ipsen, Medtronic, Merck Serono, Merz Pharmaceuticals, Novartis, and Solvay. Dr. Kowarik has received research support from Novartis and has received funding for travel from Merck Serono and Bayer Schering Pharma. Dr. Albrecht has received funding for research from Novartis and funding for travel from Merck Serono, Teva, Biogen Idec, Bayer Schering Pharma, and Novartis. Dr. Krause has received funding for research from Novartis and funding for advisory boards, funding for travel, and speaker honoraria from Merck Serono, Teva, Biogen Idec, Bayer Schering Pharma, Novartis, and Merz Pharmaceuticals. Dr. Haslinger has served on a scientific advisory board for Merz Pharmaceuticals; received funding for travel from Biogen Idec, Ipsen, Medtronic, and Merz Pharmaceuticals; has received speaker honoraria from Allergan, Desitin Pharmaceuticals, GlaxoSmithKline, Ipsen, and Novartis; and receives research support from Ipsen and the German Research Foundation (DFG). Dr. Zimmer has received funding for research from ACI Immune S.A., Actelion Pharmaceuticals, Affiris, Biogen Idec, Concentric Medical, FGK Clinical Research, Genzyme, Invade, Medivation, Medtronic Spinal and Biologics Europe, NeuroRx Research, Novartis, Omnicare Clinical Research, Galapagos NV, Penumbra, Pfizer, Pharmtrace, Premier Research Germany, Qintiles, Reverse Medical, Roche, and Surpass Medical; and receives research support from the German Research Foundation (DFG and BMBF) and the Bavarian Research Foundation . Dr. Berthele has received funding for travel and speaker honoraria from Biogen Idec, Merck Serono, Novartis, Teva, and Bayer Schering Pharma; and has received funding for research from Bayer Schering Pharma . Dr. Hemmer has served on scientific advisory boards for and received funding for travel or speaker honoraria from Novartis, Bayer Schering Pharma, Biogen Idec, Merck Serono, Roche, Micromet and Novartis; serves as a consultant for Gerson Lehrman Group; and has received research support from Novartis, Roche, Bayer Schering Pharma, Biogen Idec, Metanomics, Protagen, Merck Serono, DFG, BMBF, and Hertie Foundation. ",

year = "2012",

month = mar,

day = "20",

doi = "10.1212/WNL.0b013e31824c46ad",

language = "English",

volume = "78",

pages = "928--930",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "12",

}

TY - JOUR

T1 - Clinical/scientific notes

AU - Castrop, F.

AU - Kowarik, M. C.

AU - Albrecht, H.

AU - Krause, M.

AU - Haslinger, B.

AU - Zimmer, C.

AU - Berthele, A.

AU - Hemmer, B.

N1 - Funding Information: Dr. Castrop has received funding for travel from Allergan, Biogen Idec, Ipsen, Medtronic, Merck Serono, Merz Pharmaceuticals, Novartis, and Solvay. Dr. Kowarik has received research support from Novartis and has received funding for travel from Merck Serono and Bayer Schering Pharma. Dr. Albrecht has received funding for research from Novartis and funding for travel from Merck Serono, Teva, Biogen Idec, Bayer Schering Pharma, and Novartis. Dr. Krause has received funding for research from Novartis and funding for advisory boards, funding for travel, and speaker honoraria from Merck Serono, Teva, Biogen Idec, Bayer Schering Pharma, Novartis, and Merz Pharmaceuticals. Dr. Haslinger has served on a scientific advisory board for Merz Pharmaceuticals; received funding for travel from Biogen Idec, Ipsen, Medtronic, and Merz Pharmaceuticals; has received speaker honoraria from Allergan, Desitin Pharmaceuticals, GlaxoSmithKline, Ipsen, and Novartis; and receives research support from Ipsen and the German Research Foundation (DFG). Dr. Zimmer has received funding for research from ACI Immune S.A., Actelion Pharmaceuticals, Affiris, Biogen Idec, Concentric Medical, FGK Clinical Research, Genzyme, Invade, Medivation, Medtronic Spinal and Biologics Europe, NeuroRx Research, Novartis, Omnicare Clinical Research, Galapagos NV, Penumbra, Pfizer, Pharmtrace, Premier Research Germany, Qintiles, Reverse Medical, Roche, and Surpass Medical; and receives research support from the German Research Foundation (DFG and BMBF) and the Bavarian Research Foundation . Dr. Berthele has received funding for travel and speaker honoraria from Biogen Idec, Merck Serono, Novartis, Teva, and Bayer Schering Pharma; and has received funding for research from Bayer Schering Pharma . Dr. Hemmer has served on scientific advisory boards for and received funding for travel or speaker honoraria from Novartis, Bayer Schering Pharma, Biogen Idec, Merck Serono, Roche, Micromet and Novartis; serves as a consultant for Gerson Lehrman Group; and has received research support from Novartis, Roche, Bayer Schering Pharma, Biogen Idec, Metanomics, Protagen, Merck Serono, DFG, BMBF, and Hertie Foundation.

PY - 2012/3/20

Y1 - 2012/3/20

UR - http://www.scopus.com/inward/record.url?scp=84860344893&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e31824c46ad

DO - 10.1212/WNL.0b013e31824c46ad

M3 - Article

C2 - 22402856

AN - SCOPUS:84860344893

SN - 0028-3878

VL - 78

SP - 928

EP - 930

JO - Neurology

JF - Neurology

IS - 12

ER -